Umutlu L - Search Results

1

Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapy.

Ferdinandus J, Metzenmacher M, Kessler L, Umutlu L, Aigner C, Karl KO, Grünwald V, Eberhardt W, Fendler WP, Herrmann K, Faehling M, Christoph DC. Ferdinandus J, et al. Among authors: umutlu l. J Immunother Cancer. 2021 Mar;9(3):e002262. doi: 10.1136/jitc-2020-002262. J Immunother Cancer. 2021. PMID: 33789880 Free PMC article.

2

Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI.

Schaarschmidt BM, Buchbender C, Nensa F, Grueneisen J, Gomez B, Köhler J, Reis H, Ruhlmann V, Umutlu L, Heusch P. Schaarschmidt BM, et al. Among authors: umutlu l. PLoS One. 2015 Jan 9;10(1):e0116277. doi: 10.1371/journal.pone.0116277. eCollection 2015. PLoS One. 2015. PMID: 25574968 Free PMC article.

3

Evaluation of the Outcome of Lung Nodules Missed on 18F-FDG PET/MRI Compared with 18F-FDG PET/CT in Patients with Known Malignancies.

Sawicki LM, Grueneisen J, Buchbender C, Schaarschmidt BM, Gomez B, Ruhlmann V, Umutlu L, Antoch G, Heusch P. Sawicki LM, et al. Among authors: umutlu l. J Nucl Med. 2016 Jan;57(1):15-20. doi: 10.2967/jnumed.115.162966. Epub 2015 Oct 29. J Nucl Med. 2016. PMID: 26514173 Free article.

4

Thoracic staging with ¹⁸F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to ¹⁸F-FDG PET/CT?

Schaarschmidt BM, Grueneisen J, Metzenmacher M, Gomez B, Gauler T, Roesel C, Heusch P, Ruhlmann V, Umutlu L, Antoch G, Buchbender C. Schaarschmidt BM, et al. Among authors: umutlu l. Eur Radiol. 2017 Feb;27(2):681-688. doi: 10.1007/s00330-016-4397-0. Epub 2016 May 14. Eur Radiol. 2017. PMID: 27180186

5

Value of ¹⁸ F-FDG PET/MRI for the outcome of CT-guided facet block therapy in cervical facet syndrome: initial results.

Sawicki LM, Schaarschmidt BM, Heusch P, Buchbender C, Rosenbaum-Krumme S, Umutlu L, Eicker SO, Bockisch A, Antoch G, Floeth FW. Sawicki LM, et al. Among authors: umutlu l. J Med Imaging Radiat Oncol. 2017 Jun;61(3):327-333. doi: 10.1111/1754-9485.12565. Epub 2016 Nov 25. J Med Imaging Radiat Oncol. 2017. PMID: 27885810

6

¹⁸F-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed?

Kirchner J, Deuschl C, Grueneisen J, Herrmann K, Forsting M, Heusch P, Antoch G, Umutlu L. Kirchner J, et al. Among authors: umutlu l. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1005-1013. doi: 10.1007/s00259-017-3635-2. Epub 2017 Feb 4. Eur J Nucl Med Mol Imaging. 2017. PMID: 28161723

7

Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT.

Kirchner J, Sawicki LM, Suntharalingam S, Grueneisen J, Ruhlmann V, Aktas B, Deuschl C, Herrmann K, Antoch G, Forsting M, Umutlu L. Kirchner J, et al. Among authors: umutlu l. PLoS One. 2017 Feb 22;12(2):e0172553. doi: 10.1371/journal.pone.0172553. eCollection 2017. PLoS One. 2017. PMID: 28225831 Free PMC article.

8

Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI: a feasibility study.

Deuschl C, Moenninghoff C, Goericke S, Kirchner J, Köppen S, Binse I, Poeppel TD, Quick HH, Forsting M, Umutlu L, Herrmann K, Hense J, Schlamann M. Deuschl C, et al. Among authors: umutlu l. Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1285-1295. doi: 10.1007/s00259-017-3661-0. Epub 2017 Mar 3. Eur J Nucl Med Mol Imaging. 2017. PMID: 28258444

9

Diagnostic impact of integrated 18F-FDG PET/MRI in cerebral staging of patients with non-small cell lung cancer.

Deuschl C, Nensa F, Grueneisen J, Poeppel TD, Sawicki LM, Heusch P, Gramsch C, Mönninghoff C, Quick HH, Forsting M, Umutlu L, Schlamann M. Deuschl C, et al. Among authors: umutlu l. Acta Radiol. 2017 Aug;58(8):991-996. doi: 10.1177/0284185116681041. Epub 2016 Dec 14. Acta Radiol. 2017. PMID: 28273734

10

Evaluation of ⁶⁸Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with ⁶⁸Ga-DOTATOC PET/CT.

Sawicki LM, Deuschl C, Beiderwellen K, Ruhlmann V, Poeppel TD, Heusch P, Lahner H, Führer D, Bockisch A, Herrmann K, Forsting M, Antoch G, Umutlu L. Sawicki LM, et al. Among authors: umutlu l. Eur Radiol. 2017 Oct;27(10):4091-4099. doi: 10.1007/s00330-017-4803-2. Epub 2017 Apr 24. Eur Radiol. 2017. PMID: 28439648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page